Christa received her bachelor’s in biochemistry from the University of California, San Diego (UCSD) in 2014 and master’s from Boston University. Her work centers on cancer biology and patient outcomes. She is taking time off from medical school at Boston University School of Medicine (BUSM) to support research on the etiology of sex differences in bladder cancer at Cedars-Sinai.
Deblina completed her doctorate at the Institute for Stem Cell Science and Regenerative Medicine, India. Her previous work used mouse- and cell-based models to study injury and stress response-related pathways in the lung; areas of expertise include mammalian cell culture, immunoblotting and histochemical analysis. At Cedars-Sinai, she is studying sex differences in bladder cancer development.
Zonghao received his doctorate in developmental biology from Fujian Normal University in 2018. Before joining the Li Lab, he was deciphering the mechanism of gonad development in both males and females. Now at Cedars-Sinai, he is investigating bladder tumorigenesis using genetic mice, organoid and tumoroid models.
Xing Ye received his master's degree in surgery from Southern Medical University, China, in 2021. He uses high-resolution episcopic microscope 3D morphometric technology to study urinary tract development, birth defects relating to umbilical arteries and congenital heart diseases; he also uses NGS technology to study sex differences in bladder cancer.
Yingsheng received his doctorate degree in cancer biology from Purdue University in 2020. His work there analyzed how therapeutics targeted the epigenetic and metabolic reprogramming in triple-negative breast cancer. At Cedars-Sinai, he is studying how a differential sex epigenome leads to sex disparities in bladder cancer incidence.